City Therapeutics Ord Shs (CTY) Stock Price & News

All values in USD	Mar 2025	Jun 2025	Mar 2026	Jun 2026
Revenue	2.79M	2.79M	3.18M	3.18M
Cost of goods sold	12.19M	12.19M	23.16M	23.16M
Cost of revenue	12.19M	12.19M	23.16M	23.16M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	3.90M	3.90M	5.58M	5.58M
Operating expense	3.90M	3.90M	5.58M	5.58M
Total operating expenses	16.09M	16.09M	28.74M	28.74M
Operating income	-13.30M	-13.30M	-25.57M	-25.57M
Other non operating income	-65.50K	-65.50K	-1.21M	-1.21M
EBT including unusual items	-12.14M	-12.14M	-26.72M	-26.72M
EBT excluding unusual items	-12.65M	-12.65M	-26.72M	-26.72M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-12.14M	-12.14M	-26.72M	-26.72M
Net profit margin	-435.32%	-435.32%	-840.56%	-840.56%
Earnings per share	-	-	-	-
Interest and investment income	1.03M	1.03M	797.50K	797.50K
Interest expense	-323.00K	-323.00K	-748.00K	-748.00K
Net interest expenses	709.00K	709.00K	49.50K	49.50K
Depreciation and amortization charges	-	-	-	-
EBITDA	-13.04M	-13.04M	-25.16M	-25.16M
Gain or loss from assets sale	-	-	-	-

Finance